John M. Asara received his Ph.D. in Analytical Chemistry in 1999 from Michigan State University with a specialization in mass spectrometry. He then pursued his postdoctoral studies at Harvard University and is currently an Associate Professor of Medicine at Harvard Medical School and he is Director of the Mass Spectrometry Core at the Beth Israel Deaconess Medical Center in Boston, MA. He has developed technologies to help analyze phosphoproteins, DNA, metabolites and lipids in his Harvard based laboratories over the last 15+ years. He has co-authored more than 235 scientific publications and a life long passion for horses and he and his family own three horses at their small MA farm. He recently developed technologies to integrate metabolomics, lipidomics and proteomics and will apply this to equine performance testing from blood strips, urine and hair. He decided to offer these -omics technologies to the equine industry in late 2018 in order to determine performance biomarkers in racehorses, rodeo horses and eventers or any other horse owners who wishes to assess the biochemical profile of their horse's blood. The company is called TriomicsEquine, LLC (www.triomicsequine.com). He has an ongoing collaboration with NYRA trainers testing the technology and biomarker test results have correlated with racehorse performance. The analyses can be used to help monitor training or choose horses to purchase at sales. John currently is a licensed owner in six different states (NY, MA, PA, OH, MD and WV) and has two horses in training and is planning to enter the breeding aspect of the business in 2020.